Apply to Attend 11th Executive Congress on Translational Medicine, Biotech Innovation & Clinical Strategy
This congress follows an executive-only admission model designed to maintain a senior, high-value environment for translational medicine leaders, biotech innovators, clinical researchers, pharma strategists, digital health executives, healthcare investors, hospital decision-makers, and selected industry partners. Delegates are invited to apply so that each confirmed participant aligns with the quality, relevance, and collaborative objectives of the meeting.
To ensure discussions remain focused, practical, and relevant for senior researchers, clinicians, biotech executives, pharma leaders, and healthcare innovation decision-makers.
Applications help us understand your objectives, clinical priorities, innovation focus, and how participation can best support your goals.
Attendance is intentionally selective to preserve quality networking, executive exchange, and meaningful clinical, biotech, and industry partnerships.